UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

: Sporanox-10mgml-Solution-SE-IS-APD - JSON Representation

Raw json | Download


{
  "resourceType" : "AdministrableProductDefinition",
  "id" : "Sporanox-10mgml-Solution-SE-IS-APD",
  "meta" : {
    "profile" : [
      🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLAdministrableProductDefinition"
    ]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: AdministrableProductDefinition Sporanox-10mgml-Solution-SE-IS-APD</b></p><a name=\"Sporanox-10mgml-Solution-SE-IS-APD\"> </a><a name=\"hcSporanox-10mgml-Solution-SE-IS-APD\"> </a><a name=\"hcSporanox-10mgml-Solution-SE-IS-APD-en-US\"> </a><p><b>status</b>: Active</p><p><b>formOf</b>: <a href=\"MedicinalProductDefinition-Sporanox-10mgml-Solution-SE-IS-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100003163-00013358,http://ema.europa.eu/fhir/eurdId#1798; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Oral solution; indication = Sporanox oral lösning är indicerad: - för behandling av oral och/eller esofageal candidiasis hos HIV-positiva patienter eller andra  patienter med nedsatt immunförsvar. - som profylax, mot djupa svampinfektioner som förutses vara itrakonazolkänsliga, hos  patienter med hematologisk malignitet eller som genomgår benmärgstransplantation och som  förväntas bli neutropena (dvs. &lt;0,5 x 109 /l) när standardterapi anses olämplig. För närvarande  är data över klinisk effekt vid aspergillosprofylax otillräckliga. Hänsyn ska tas till nationella och/eller lokala behandlingsrekommendationer för antimykotika.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = J02AC02</a></p><p><b>administrableDoseForm</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000000004 100000073646}\">Oral solution</span></p><p><b>producedFrom</b>: <a href=\"ManufacturedItemDefinition-Sporanox-10mgml-Solution-SE-IS-MID.html\">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Oral solution; unitOfPresentation = Bottle</a></p><h3>RouteOfAdministrations</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000073345 100000073619}\">Oral use</span></td></tr></table></div>"
  },
  "status" : "active",
  "formOf" : [
    {
      🔗 "reference" : "MedicinalProductDefinition/Sporanox-10mgml-Solution-SE-IS-MPD"
    }
  ],
  "administrableDoseForm" : {
    "coding" : [
      {
        "system" : "https://spor.ema.europa.eu/v1/lists/200000000004",
        "code" : "100000073646",
        "display" : "Oral solution"
      }
    ]
  },
  "producedFrom" : [
    {
      🔗 "reference" : "ManufacturedItemDefinition/Sporanox-10mgml-Solution-SE-IS-MID"
    }
  ],
  "routeOfAdministration" : [
    {
      "code" : {
        "coding" : [
          {
            "system" : "https://spor.ema.europa.eu/v1/lists/100000073345",
            "code" : "100000073619",
            "display" : "Oral use"
          }
        ]
      }
    }
  ]
}